University of Tasmania
67328, Journal Article.pdf (5.75 MB)

A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in Multiple Sclerosis

Download (5.75 MB)
journal contribution
posted on 2023-05-17, 04:43 authored by Riveros, C, Mellor, D, Gandhi, KS, McKay, FC, Cox, MB, Berretta, R, Vaezpour, SY, Inostroza-Ponta, M, Broadley, SA, Heard, RN, Vucic, S, Stewart, GJ, Williams, DW, Scott, RJ, Lechner-Scott, J, Booth, DR, Moscato, P, Bahlo, M, Brown, MA, Browning, BL, Browning, SR, Butzkueven, H, Carroll, WM, Danoy, P, Field, J, Simon James FooteSimon James Foote, Griffiths, LR, Kermode, AG, Kilpatrick, TJ, Mason, D, Perreau, VM, Slee, M, Jim Stankovich, Bruce TaylorBruce Taylor, Wiley, J
Background: Several lines of evidence suggest that transcription factors are involved in the pathogenesis of Multiple Sclerosis (MS) but complete mapping of the whole network has been elusive. One of the reasons is that there are several clinical subtypes of MS and transcription factors that may be involved in one subtype may not be in others. We investigate the possibility that this network could be mapped using microarray technologies and contemporary bioinformatics methods on a dataset derived from whole blood in 99 untreated MS patients (36 Relapse Remitting MS, 43 Primary Progressive MS, and 20 Secondary Progressive MS) and 45 age-matched healthy controls. Methodology/Principal Findings: We have used two different analytical methodologies: a non-standard differential expression analysis and a differential co-expression analysis, which have converged on a significant number of regulatory motifs that are statistically overrepresented in genes that are either differentially expressed (or differentially co-expressed) in cases and controls (e.g., V$KROX_Q6, p-value ,3.31E-6; V$CREBP1_Q2, p-value ,9.93E-6, V$YY1_02, p-value ,1.65E-5). Conclusions/Significance: Our analysis uncovered a network of transcription factors that potentially dysregulate several genes in MS or one or more of its disease subtypes. The most significant transcription factor motifs were for the Early Growth Response EGR/KROX family, ATF2, YY1 (Yin and Yang 1), E2F-1/DP-1 and E2F-4/DP-2 heterodimers, SOX5, and CREB and ATF families. These transcription factors are involved in early T-lymphocyte specification and commitment as well as in oligodendrocyte dedifferentiation and development, both pathways that have significant biological plausibility in MS causation.


Publication title

P L o S One










Menzies Institute for Medical Research


Public Library of Science

Place of publication

United States

Rights statement

Copyright: © 2010 Riveros et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Repository Status

  • Open

Socio-economic Objectives

Clinical health not elsewhere classified

Usage metrics

    University Of Tasmania


    Ref. manager